Brendan Hannah
Director Financiero/CFO en QUINCE THERAPEUTICS, INC. .
Fortuna: 265 344 $ al 30/04/2024
Cargos activos de Brendan Hannah
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
QUINCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 16/03/2023 | - |
Director de Operaciones | 24/10/2023 | - | |
Director Financiero/CFO | 16/03/2023 | - | |
Corporate Officer/Principal | 01/05/2022 | 16/03/2023 | |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Director de Operaciones | - | - |
Historial de carrera de Brendan Hannah
Antiguos cargos conocidos de Brendan Hannah.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | - | 01/12/2016 |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formación de Brendan Hannah.
University of California | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Corporate Officer/Principal | 3 |
Chief Operating Officer | 2 |
Comptroller/Controller/Auditor | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
QUINCE THERAPEUTICS, INC. | Health Technology |
CIDARA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Brendan Hannah
- Experiencia